Prognostic value of early response assessment using (18F)FDG-PET in patients with advanced non-small cell lung cancer treated with tyrosine-kinase inhibitors
Jun Ma, Xiaojing Wu, Jianghong Li, Zhihua Wang, Yi Wang
DOI: 10.1136/jim-2017-000433 Published 30 March 2017
Jun Ma
1Department of Thoracic surgery, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, China
Xiaojing Wu
2Department of Respiratory Medicine, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, China
Jianghong Li
1Department of Thoracic surgery, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, China
Zhihua Wang
1Department of Thoracic surgery, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, China
Yi Wang
1Department of Thoracic surgery, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, China
No eLetters have been published for this article.
Prognostic value of early response assessment using (18F)FDG-PET in patients with advanced non-small cell lung cancer treated with tyrosine-kinase inhibitors
Jun Ma, Xiaojing Wu, Jianghong Li, Zhihua Wang, Yi Wang
Journal of Investigative Medicine Mar 2017, jim-2017-000433; DOI: 10.1136/jim-2017-000433
Prognostic value of early response assessment using (18F)FDG-PET in patients with advanced non-small cell lung cancer treated with tyrosine-kinase inhibitors
Jun Ma, Xiaojing Wu, Jianghong Li, Zhihua Wang, Yi Wang
Journal of Investigative Medicine Mar 2017, jim-2017-000433; DOI: 10.1136/jim-2017-000433
Prognostic value of early response assessment using (18F)FDG-PET in patients with advanced non-small cell lung cancer treated with tyrosine-kinase inhibitors
Jun Ma, Xiaojing Wu, Jianghong Li, Zhihua Wang, Yi Wang
Journal of Investigative Medicine Mar 2017, jim-2017-000433; DOI: 10.1136/jim-2017-000433